Press "esc" to clear
Go to Advanced Search

Showing results

110 of 1155
Embargo will expire:
22-Oct-2018 11:00 AM EDT
Released to reporters:
21-Oct-2018 11:00 AM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 22-Oct-2018 11:00 AM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Article ID: 702485

Updated Global Immuno-Oncology Landscape Report Highlights Robust International Pipeline Marked by Rapid Growth

Cancer Research Institute

The Cancer Research Institute has updated its analysis of the global immuno-oncology landscape, published today in Nature Reviews Drug Discovery.

Released:
19-Oct-2018 10:05 AM EDT
1200px-Pathway_through_Camptotheca_acuminata_-_Chengdu_Botanical_Garden_-_Chengdu_China_-_DSC03513.jpg

Article ID: 702398

Compound Derived From Chinese Tree Bark Shows Promise as Treatment for Pancreatic Cancer

Roswell Park Comprehensive Cancer Center

A new derivative of a compound found in the bark of a rare Chinese tree has powerful anticancer properties and a low toxicity profile, according to new research from a Roswell Park Comprehensive Cancer Center published in the Journal of Experimental & Clinical Cancer Research.

Released:
18-Oct-2018 7:00 AM EDT
JWPheadshot.jpg

Article ID: 702333

The Association of American Cancer Institutes Appoints New Executive Director

Association of American Cancer Institutes (AACI)

Jennifer W. Pegher, MA, is the new executive director of the Association of American Cancer Institutes. She is the second executive director in AACI's 19-year history, succeeding founding executive director Barbara Duffy Stewart, who retired earlier this month.

Released:
17-Oct-2018 10:05 AM EDT
biospecimenhistopathologysharedresource.jpg

Article ID: 702221

Rutgers Cancer Institute of New Jersey Biospecimen Repository and Histopathology Service Shared Resource Receives Accreditation from College of American Pathologists

Rutgers Cancer Institute of New Jersey

The Biospecimen Repository and Histopathology Service shared resource at Rutgers Cancer Institute of New Jersey has received accreditation from the College of American Pathologists (CAP) based on results of a recent on-site inspection as part of the CAP’s Accreditation Programs.

Released:
15-Oct-2018 3:05 PM EDT

Article ID: 702146

Updated Breast Cancer Resources and Events from NCCN Keep Patients and Doctors Worldwide Informed during Breast Cancer Awareness Month

National Comprehensive Cancer Network® (NCCN®)

NCCN publishes updated patient and clinical guidelines for breast cancer in conjunction with free webinars. New NCCN Harmonized Guidelines for the Caribbean released for breast cancer and other types. Global Summit on International Breast Health and Cancer Control begins.

Released:
15-Oct-2018 9:45 AM EDT
Mayumi.Fujita.2.jpg

Article ID: 702110

Cancer Stem Cells Use “Normal” Genes in Abnormal Ways

University of Colorado Cancer Center

University of Colorado Cancer Center study shows that "normal" gene CDK1 interacts with "abnormal" gene Sox2 to keep cancer stem cells "stemmy."

Released:
12-Oct-2018 8:05 AM EDT

Article ID: 702028

Fred Hutch November Tip Sheet

Fred Hutchinson Cancer Research Center

Fred Hutch is committed to better understanding prostate cancer, creating new treatment therapies and technologies and ultimately, finding a cure. This tip sheet includes brief summaries of the work our researchers are doing around prostate cancer and some high-level points to be aware of.

Released:
11-Oct-2018 2:05 AM EDT
Rezvani_K2.jpg
  • Embargo expired:
    10-Oct-2018 5:00 PM EDT

Article ID: 701795

Cancer Patients with Rare Deadly Brain Infection Treated Successfully with Off-the-Shelf Adoptive T-Cell Therapy in Clinical Trial

University of Texas M. D. Anderson Cancer Center

An emerging treatment known as adoptive T-cell therapy has proven effective in a Phase II clinical trial for treating progressive multifocal leukoencephalopathy (PML), a rare and often fatal brain infection sometimes observed in patients with cancer and other diseases in which the immune system is compromised. The study, led by Katy Rezvani, M.D., Ph.D., professor, Department of Stem Cell Transplantation and Cellular Therapy at The University of Texas MD Anderson Cancer Center, showed marked improvement in three PML patients infused with donor T cells targeting the BK virus. Findings were published in the Oct. 11 online issue of the New England Journal of Medicine.

Released:
9-Oct-2018 5:00 PM EDT
NET_PtGL_Cover_Screenshot.JPG

Article ID: 701858

Navigating Neuroendocrine Tumors

National Comprehensive Cancer Network® (NCCN®)

New NCCN Guidelines for Patients: NET provides background and treatment information for neuroendocrine tumors, the type of cancer experienced by Aretha Franklin and Steve Jobs

Released:
9-Oct-2018 9:00 AM EDT

Showing results

110 of 1155

Chat now!